C.A. Tyson
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 7
- Pharmacogenetics and Drug Metabolism 3
-
- Animal testing and alternatives 2
- Co-authors
- D E Green (2 shared papers)Harold Vande Zande (2 shared papers)Shirley J. Gee (4 shared papers)David L. Story (3 shared papers)IRWIN C. GUNSALUS (1 shared paper)John D. Lipscomb (1 shared paper)R.L. Tsai (1 shared paper)Jack E. Dabbs (2 shared papers)
- Journals
- Toxicology in Vitro (6 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Biological Chemistry (2 papers)Chemico-Biological Interactions (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
C.A. Tyson
20 papers receiving 740 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 160
- Biochemistry 63
- Dermatology 77
- Small Animals 58
- Inorganic Chemistry 85
Countries citing papers authored by C.A. Tyson
This map shows the geographic impact of C.A. Tyson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Tyson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Tyson more than expected).
Fields of papers citing papers by C.A. Tyson
This network shows the impact of papers produced by C.A. Tyson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Tyson. The network helps show where C.A. Tyson may publish in the future.
Co-authors
The 25 scholars most cited alongside C.A. Tyson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 254 | |
| 2 | 1975 | 105 | |
| 3 | Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters. | 1998 | 80 |
| 4 | 1976 | 62 | |
| 5 | 1983 | 59 | |
| 6 | 1986 | 58 | |
| 7 | 1975 | 49 | |
| 8 | 1971 | 46 | |
| 9 | 1977 | 31 | |
| 10 | 1984 | 31 | |
| 11 | 1983 | 20 | |
| 12 | 2006 | 17 | |
| 13 | 2005 | 16 | |
| 14 | 1984 | 10 | |
| 15 | 1990 | 7 | |
| 16 | 1990 | 6 | |
| 17 | 1990 | 6 | |
| 18 | 1983 | 4 | |
| 19 | 1989 | 3 | |
| 20 | 1995 | 2 |
About C.A. Tyson
C.A. Tyson is a scholar working on Pharmacology, Small Animals, Cancer Research, Inorganic Chemistry and Molecular Biology, having authored 20 papers that have together received 866 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (7 papers), Mitochondrial Function and Pathology (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), ATP Synthase and ATPases Research (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Animal testing and alternatives (2 papers), Metal-Catalyzed Oxygenation Mechanisms (2 papers) and Lipid Membrane Structure and Behavior (1 paper). The work is most often cited by research in Pharmacology (160 citations), Biochemistry (63 citations), Dermatology (77 citations), Small Animals (58 citations) and Inorganic Chemistry (85 citations). C.A. Tyson has collaborated with scholars based in United States and Japan. Frequent co-authors include D E Green, Harold Vande Zande, Shirley J. Gee, David L. Story, IRWIN C. GUNSALUS, John D. Lipscomb, R.L. Tsai, Jack E. Dabbs, Carol E. Green and Kayoko Niinuma. Their work appears in journals such as Toxicology in Vitro, Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics, Journal of Biological Chemistry and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.